Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6286281

NCCCC[C@](N)(C(=O)Cc1ccccc1)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@](N)(CCCCN)C(=O)Cc3ccccc3)cc2)c2ccc(NC(=O)[C@](N)(CCCCN)C(=O)Cc3ccccc3)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.39
LTA4H P09960 2/20 0.36
FPR2 P25090 2/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CNR2 P34972 1/20 0.34
HDAC3 O15379 2/20 0.33
HDAC4 P56524 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC7 Q8WUI4 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC10 Q969S8 2/20 0.33
HDAC11 Q96DB2 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
HDAC9 Q9UKV0 2/20 0.33
HDAC5 Q9UQL6 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6288018 1.00 CES1 (0.39) CES1LTA4HFPR2NPC1LMNA
Trifluoroacetic Acid SCHEMBL7035307 0.89 CES1 (0.40) CES1LTA4HNPC1GAARAB9A
Trifluoroacetic Acid SCHEMBL6287794 0.86 MLYCD (0.37) CES1LTA4HNPC1LMNARAB9A
Trifluoroacetic Acid SCHEMBL6290918 0.86 MLYCD (0.37) CES1LTA4HNPC1LMNARAB9A
Hydrochloric Acid SCHEMBL6286778 0.85 LTA4H (0.52) LTA4HNPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL6287205 0.84 GAA (0.36) LTA4HGAASMN1; SMN2HDAC4MAPT
Hydrochloric Acid SCHEMBL7108341 0.84 GAA (0.36) LTA4HGAASMN1; SMN2HDAC4MAPT
Trifluoroacetic Acid SCHEMBL6290842 0.84 MC3R (0.44) LMNASMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL6287934 0.83 CA1 (0.37) NPC1RAB9ASMN1; SMN2CA1CA2
Hydrochloric Acid SCHEMBL6286600 0.83 CHRNA1 (0.37) LTA4HLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US claimed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US claimed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP claimed
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK CES1 3335/4885LTA4H 1938/4885FPR2 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.